Home Business & Finance Novo Still Has Work to Do to Build Investor Confidence, CEO Says
Business & Finance

Novo Still Has Work to Do to Build Investor Confidence, CEO Says

Key Points

Novo CEO Mike Doustdar discusses investor confidence, drug testing and the potential for expanding the firm's obesity offerings. "We should also have a mindset that we don't have a patent or a monopoly on all the good ideas," Doustdar tells Bloomberg Television. "When there is a gap, strategically or scientifically, we're looking outside to see how we can fill the gaps."

Novo CEO Mike Doustdar discusses investor confidence, drug testing and the potential for expanding the firm's obesity offerings. "We should also have a mindset that we don't have a patent or a monopoly on all the good ideas," Doustdar tells Bloomberg Television. "When there is a gap, strategically or scientifically, we're looking outside to see how we can fill the gaps." (Source: Bloomberg)
Novo (ORG) Mike Doustdar (PERSON) Doustdar (PERSON) Bloomberg Television (ORG)
Originally published by Bloomberg Markets Read original →